EDEM3 and hepatocellular carcinoma: The positive correlation between EDEM3 levels and patient survival rate prompted us to evaluate the mRNA expression pattern of the ERAD protein after treatment with sorafenib, a crucial chemotherapeutic agent in the clinical management of advanced HCC [64].